A case of ROS1 ‐rearranged lung adenocarcinoma exhibiting pleural effusion caused by crizotinib-Reference-Cited by-同舟云学术

A case of ROS1 ‐rearranged lung adenocarcinoma exhibiting pleural effusion caused by crizotinib

Published:2020-05-20 Issue:7 Volume:11 Page:2063-2066
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Tachi Hiroaki¹^ORCID,Nishino Kengo¹,Nakaizumi Taisuke¹,Kuramoto Kenya¹,Shimizu Kei¹,Yamamoto Yusuke¹,Kobayashi Keisuke²,Ichimura Hideo²,Sakata Akiko³,Nawa Takeshi¹

Affiliation:

1. Department of Respiratory MedicineHitachi General Hospital, Hitachi Ltd. Hitachi City Japan

2. Department of Thoracic SurgeryHitachi General Hospital, Hitachi Ltd. Hitachi City Japan

3. Department of PathologyHitachi General Hospital, Hitachi Ltd. Hitachi City Japan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13496

Reference12 articles.

1. ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers

2. Identifying and Targeting ROS1 Gene Fusions in Non–Small Cell Lung Cancer

3. Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer

4. The protein tyrosine kinase family of the human genome

5. Severe Acute Interstitial Lung Disease After Crizotinib Therapy in a Patient With EML4-ALK–Positive Non–Small-Cell Lung Cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Waldenström macroglobulinemia presenting as bilateral bloody pleural effusion: A case report;Medicine;2024-06-14

2. Safety of MET Tyrosine Kinase Inhibitors in Patients With MET Exon 14 Skipping Non-small Cell Lung Cancer: A Clinical Review;Clinical Lung Cancer;2022-05

3. Multiple drugs;Reactions Weekly;2020-07